跳至主要内容
临床试验/NCT02561468
NCT02561468已完成不适用

The Preemptive Analgesic Efficacy of Nefopam

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2015年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
94
试验地点
1
主要终点
The change of pain numerical rating score from postoperative 30 min until postoperative 3 month

研究概览

简要总结

Nefopam is administered as a preemptive analgesic drug to the patient undergoing breast cancer surgery. It will be evaluated whether postoperative acute and chronic pain can be reduced.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients diagnosed with breast cancer
  • Lumpectomy with axillary lymph node dissection or Lumpectomy with sentinel lymph node biopsy
  • American Society of Anesthesiologists physical status I or II

排除标准

  • Cardiac disease
  • Monoamine oxidase inhibitor user
  • Urologic disease
  • Preoperative analgesic drug medication
  • Pregnancy
  • Recurred breast cancer patient

研究组 & 干预措施

Nefopam

Experimental

20 mg nefopam in 100 ml normal saline is infused before starting operation.

干预措施: Nefopam (Drug)

Control

Placebo Comparator

100 ml normal saline is infused before starting operation.

干预措施: Saline (Drug)

结局指标

主要结局

The change of pain numerical rating score from postoperative 30 min until postoperative 3 month

时间窗: Postoperative 30 min, postoperative 1 day, postoperative 1 week, postoperative 3 month

次要结局

  • The dose of ketorolac administered to the patient.(postoperative 1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyo-Seok Na

Dr

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验